Tumor necrosis factor receptor

From Proteopedia

Jump to: navigation, search

Contents

Function

Tumor necrosis factor receptor (TNFR) or death receptor is a trimeric cytokine receptor which binds TNF[1]. TNFR family contains several members and superfamily (TNFRSF) members.

  • TNFRSF 1 is called Lymphotoxin-α or TNF-β[2];
  • TNFRSF 3 is called TNFR-III;
  • TNFRSF 4 is called OX40L receptor;
  • TNFRSF 5 is called CD40L receptor;
  • TNFRSF 6 is called Fas;
  • TNFRSF 9 is called 4-1BBL;
  • TNFRSF 10 see TRAIL;
  • TNFRSF 10B is called Dr5;
  • TNFRSF 11A is called RANK;
  • TNFRSF 11B is called Osteoprotegerin;
  • TNFRSF 12 is called TWEAK;
  • TNFRSF 12A is called TWEAKR;
  • TNFRSF 13B is called BAFF or sTALL-1;
  • TNFRSF 13C is called BAFF receptor;
  • TNFRSF 14 is called LIGHT;
  • TNFRSF 16 is called Low-affinity nerve growth factor receptor; p75NTR; p75 neurotrophin receptor;
  • TNFRSF 18 is called GITRL;
  • TNFRSF 21 is called Dr6;
  • TNFRSF 25 is called Dr3;

See also

Relevance

TRAPS - a condition characterized by recurrent episodes of fever is associated with TNFR[3].

Structural highlights

The extracellular domain of TNFR contains 2 to 6 cysteine-rich domains (CRD). The CRD domains are ca. 40 amino-acid long and contain 4-6 cysteine residues. The CRDs are involved in binding of TNF[4]. Mg coordination site. Water molecules are shown as red spheres.

3D structures of tumor necrosis factor receptor

Tumor necrosis factor receptor 3D structures


Structure of human TNFR extracellular domain complex with sulfate and Mg+2 ion (green) (PDB code 1ext).

Drag the structure with the mouse to rotate

References

  1. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-67. PMID:10358762 doi:http://dx.doi.org/10.1146/annurev.immunol.17.1.331
  2. Mounzer RH, Svendsen OS, Baluk P, Bergman CM, Padera TP, Wiig H, Jain RK, McDonald DM, Ruddle NH. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood. 2010 Sep 23;116(12):2173-82. PMID:20566898 doi:10.1182/blood-2009-12-256065
  3. Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol. 2015 Apr;34(4):807-9. doi: 10.1007/s10067-014-2556-8. Epub 2014, Mar 11. PMID:24609716 doi:http://dx.doi.org/10.1007/s10067-014-2556-8
  4. Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996 Nov 15;4(11):1251-62. PMID:8939750

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Personal tools